Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice

Molecules. 2018 Feb 7;23(2):349. doi: 10.3390/molecules23020349.

Abstract

Pungent spice constituents such as piperine, capsaicin and [6]-gingerol consumed via daily diet or traditional Chinese medicine, have been reported to possess various pharmacological activities. These dietary phytochemicals have also been reported to inhibit P-glycoprotein (P-gp) in vitro and act as an alternative to synthetic P-gp modulators. However, the in vivo effects on P-gp inhibition are currently unknown. This study aimed to test the hypothesis that phytochemical P-gp inhibitors, i.e., piperine, capsaicin and [6]-gingerol, modulate the in vivo tissue distribution of doxorubicin, a representative P-gp substrate. Mice were divided into four groups and each group was pretreated with intraperitoneal injections of control vehicle, piperine, capsaicin, or [6]-gingerol and doxorubicin (1 mg/kg) was administered via the penile vein. The concentrations of the phytochemicals and doxorubicin in the plasma and tissues were determined by LC-MS/MS. The overall plasma concentration-time profiles of doxorubicin were not significantly affected by piperine, capsaicin, or [6]-gingerol. In contrast, doxorubicin accumulation was observed in tissues pretreated with piperine or capsaicin. The tissue to plasma partition coefficients, Kp, for the liver and kidney were higher in the piperine-pretreated group, while the Kp for kidney, brain and liver were higher in the capsaicin-pretreated group. [6]-Gingerol did not affect doxorubicin tissue distribution. The data demonstrated that the phytochemicals modulated doxorubicin tissue distribution, which suggested their potential to induce food-drug interactions and act as a strategy for the delivery of P-gp substrate drugs to target tissues and tumors.

Keywords: P-glycoprotein; [6]-gingerol; capsaicin; doxorubicin; pharmacokinetics; piperine.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors*
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism*
  • Alkaloids / pharmacokinetics
  • Animals
  • Antibiotics, Antineoplastic / pharmacokinetics*
  • Benzodioxoles / pharmacokinetics
  • Biological Transport / drug effects
  • Capsaicin / pharmacokinetics
  • Catechols / pharmacokinetics
  • Doxorubicin / pharmacokinetics*
  • Fatty Alcohols / pharmacokinetics
  • Mice
  • Phytochemicals / chemistry
  • Phytochemicals / pharmacology*
  • Piperidines / pharmacokinetics
  • Polyunsaturated Alkamides / pharmacokinetics
  • Tissue Distribution

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Alkaloids
  • Antibiotics, Antineoplastic
  • Benzodioxoles
  • Catechols
  • Fatty Alcohols
  • Phytochemicals
  • Piperidines
  • Polyunsaturated Alkamides
  • Doxorubicin
  • gingerol
  • Capsaicin
  • piperine